SEC Announces Settlement With Two Traders in Innate Insider Trading Case
August 16, 2018
August 16, 2018
WASHINGTON, Aug. 16 -- The Securities and Exchange Commission issued the following litigation release:
The Securities and Exchange Commission announced the entry of final judgments against two traders who received tips of material, nonpublic information about negative drug trial results for Innate Immunotherapeutics.
Lauren Zarsky and her mother, Dorothy Zarsky, consented to the entry of final judgments without admitting or denying the charges that they sold their share . . .
The Securities and Exchange Commission announced the entry of final judgments against two traders who received tips of material, nonpublic information about negative drug trial results for Innate Immunotherapeutics.
Lauren Zarsky and her mother, Dorothy Zarsky, consented to the entry of final judgments without admitting or denying the charges that they sold their share . . .